Materialise NV (MTLS)

Materialise NV, a leading provider of additive manufacturing software and 3D printing solutions, announced that it will host its Annual General Shareholders' Meeting and an Extraordinary Shareholders' Meeting on June 3, 2025.

The global 3D printing medical devices market is projected to grow at a CAGR of 17.1% from 2024 to 2031, driven by advancements in 3D printing technologies and rising demand for personalized healthcare solutions.

Stratasys (SSYS) and Ricoh co-sponsor a clinical study comparing the efficacy of 3D-printed models to traditional CT or MRI scanning for bone tumor excision planning.

Investors are looking for balance of top- and bottom-line growth in this environment.

ARK Invest’s 13F portfolio value decreased from $16.91B to $14.35B this quarter. Click to see the firm's trades for Q3 2022.